MENU
ADCT
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
ADC Therapeutics SA (ADCT) Earnings Date & Reports
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more
A.I. Advisor
published Earnings
ADCT is expected to report earnings to rise 90.91% to -20 cents per share on November 09
Q3'26
Est.
$-0.21
Q2'26
Beat
by $0.11
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.20
Q3'25
Beat
by $0.17
The last earnings report on August 13 showed earnings per share of -10 cents, beating the estimate of -21 cents. With 232.23K shares outstanding, the current market capitalization sits at 191.50M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry PharmaceuticalsGeneric
Industry
N/A
Address
Route de la Corniche 3B
Phone
+41 216530200
Employees
193
Web
https://www.adctherapeutics.com